Drugs for treating uncomplicated malaria in pregnant women

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2008, Pages

  Orton, Lois C ^a   Omari, Aika A A ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Antimalarials adverse effects; *therapeutic use ; Female; Humans; Malaria *drug therapy ; Mefloquine adverse effects ; Pregnancy; Pregnancy complications, parasitic *drug therapy ; Randomized controlled trials as topic; Stillbirth

Indexed keywords

AMODIAQUINE; ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; ATOVAQUONE PLUS PROGUANIL; AZITHROMYCIN; CHLOROQUINE; CLINDAMYCIN; FANSIDAR; FERROUS SULFATE; FOLIC ACID; MEFLOQUINE; QUININE; SPIRAMYCIN;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ABORTION; ANEMIA; ANOREXIA; ARTHRALGIA; BLURRED VISION; CLINICAL TRIAL; CONGENITAL MALFORMATION; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; EAR MALFORMATION; EPIDERMOID CYST; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; GASTROSCHISIS; GESTATIONAL AGE; HEADACHE; HEART PALPITATION; HUMAN; HYPOCALCEMIA; HYPOGLYCEMIA; INTRAUTERINE GROWTH RETARDATION; LOADING DRUG DOSE; LOW BIRTH WEIGHT; MALARIA; MALARIA CONTROL; META ANALYSIS; MONOTHERAPY; MYALGIA; NAUSEA; NEUROLOGIC DISEASE; NEWBORN DEATH; NEWBORN JAUNDICE; PARASITE; PERINATAL ASPHYXIA; PERINATAL DEATH; PREGNANT WOMAN; PREMATURE LABOR; PREMATURITY; PRURITUS; QUANTITATIVE ANALYSIS; REVIEW; SEPSIS; SIDE EFFECT; SYSTEMATIC REVIEW; TINNITUS; TREATMENT FAILURE; TREATMENT OUTCOME; VERTIGO; VOMITING; WEAKNESS;

EID: 55049135948     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004912.pub3     Document Type: Review

References (54)

1. Bounyasong 2001 {published data only} Bounyasong S. Randomized trial of artesunate and mefloquine in comparison with quinine sulphate to treat P. falciparum malaria pregnant women. Journal of the Medical Association of Thailand 2001;84(9):1289-98.
2. Coulibaly 2006 {published data only} Coulibaly SO, Nezien D, Traore S, Kone B, Magnussen P. Therapeutic efficacy of sulphadoxine- pyrimethamine and chloroquine for the treatment of uncomplicated malaria in pregnancy in Burkina Faso. Malaria Journal 2006;5:49.
3. Kalilani 2007 {published data only} Kalilani L, Mofolo I, Chaponda M, Rogerson SJ, Alker AP, Kwiek JJ, et al. A randomized controlled pilot trial of azithromycin or artesunate added to sulphadoxine-pyrimethamine as treatment for malaria in pregnant women. PLos ONE 2007;11:1-10.
4. Mbanzulu 1993 {published data only} Mbanzulu PN, Tona L, Nekwei W, Kobota V, Kisile M, Makengo M. Management of malaria during pregnancy in Kinshasa (Zaire) by chloroquine and clindamycin [Traitment du paludisme de la femme enceinte a Kinshasa (Republique democratique du Congo) par la chloroquine et la clinadmycine]. Revue Francaise de Gynecologie et d'Obstetrique 1998;93(6):433-7.
5. McGready 2000 {published data only} McGready R, Brockman A, Cho T, Cho D, van Vugt M, Luxemburger C, et al. Randomized comparison of mefloquine-artesunate versus quinine in the treatment of multidrug-resistant falciparum malaria in pregnancy. Transactions of the Royal Society of Tropical Medicine and Hygiene 2000;94(6):689-93.
6. McGready 2001a {published data only} McGready R, Cho T, Samuel, Villegas L, Brockman A, van Vugt M, et al. Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy. Transactions of the Royal Society of Tropical Medicine and Hygiene 2001;95(6):651-6.
7. McGready 2005 {published data only} McGready R, Ashley EA, Moo E, Cho T, Barends M, Hutagalung R, et al. A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy. Journal of Infectious Diseases 2005;192(5):846-53.
8. Nosten 1993b {published data only} Nosten F, ter Kuile F, Thwai KL, Maelankirri L, White NJ. Spriamycin does not potentiate quinine treatment of falciparum malaria in pregnancy. Transactions of the Royal Society of Tropical Medicine and Hygiene 1993;87(3):305-6.
9. Sowunmi 1998a {published data only} Sowunmi A, Oduola AMJ, Ogundahunsi OAT, Fehintola FA, Ilesanmi OA, Akinyinka OO, et al. Randomised trial of artemether versus artemether and mefloquine for the treatment of chloroquine/sulphadoxine-pyrimethamine-resistant falciparum malaria during pregnancy. Journal of Obstetrics and Gynaecology 1998;18(4):322-7.
10. Tagbor 2006 {published data only} * Tagbor H, Bruce J, Browne E, Randal A, Greenwood B, Chandramohan D. Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial. Lancet 2006;368(9544):1349-56.
11. Tagbor H, Bruce J, Ord R, Randall A, Browne E, Greenwood B, et al. Comparison of the therapeutic efficacy of chloroquine and sulphadoxine- pyremethamine in children and pregnant women. Tropical Medicine and International Health 2007;12(11):1288-97.
12. Deen 2001 {published data only} Deen JL, von Seidlein L, Pinder M, Walraven GEL, Greenwood BM. The safety of the combination artesunate and pyrimethamine-sulphadoxine given during pregnancy. Transactions of the Royal Society of Tropical Medicine and Hygiene 2001;95(4):424-8.
13. Keuter 1990 {published data only} Keuter M, van Eijk A, Hoogstrate M, Raasveld M, van de Ree M, Ngwawe WA, et al. Comparison of chloroquine, pyrimethamine and sulfadoxine, and chloroproguanil and dapsone as treatment for falciparum malaria in pregnant and non-pregnant women, Kakamega District, Kenya. BMJ 1990;301(6750):466-70.
14. McGready 2001b {published data only} McGready R, Cho T, Keo NK, Thwai KL, Villegas L, Looaresuwan S, et al. Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum. Clinical Infectious Diseases 2001;33(12): 2009-16.
15. Naing 1998 {published data only} Naing T, Win H, Nwe YY. Falciparum malaria and pregnancy: relationship and treatment response. Southeast Asian Journal of Tropical Medicine and Public Health 1998;19(2):253-8.
16. Ndyomugyenyi 2000 {published data only} Ndyomugyenyi R, Magnussen P. Chloroquine prophylaxis, iron/folic-acid supplementation or case management of malaria attacks in primigravidae in western Uganda: effects on congenital malaria and infant haemoglobin concentrations. Annals of Tropical Medicine and Parasitology 2000;94(8):759-70.
17. Sowunmi 1998b {published data only} Sowunmi A, Ilesanmi AO, Oduloa AMJ, Omitowoju GO, Ojengbede OA. Efficacy of mefloquine in uncomplicated chloroquine-resistant falciparum malaria during pregnancy. Journal of Obstetrics and Gynaecology 1998;16(5):362-3.
18. Steketee 1996 {published data only} * Steketee RW, Wirima JJ, Hightower AW, Slutsker L, Heymann DL, Breman JG. The effect of malaria prevention in pregnancy on offspring birthweight, prematurity, and intrauterine growth retardation in rural Malawi. American Journal of Tropical Medicine and Hygiene 1996;55 Suppl 1:33-41.
19. Steketee RW, Wirima JJ, Slutsker L, Breman JG, Heymann DL. Comparability of treatment groups and risk factors for parasitemia at the first antenatal clinic visit in a study of malaria treatment and prevention in pregnancy in rural Malawi. American Journal of Tropical Medicine and Hygiene 1996;55 Suppl 1:17-23.
20. Steketee RW, Wirima JJ, Slutsker L, Khoromana CO, Heymann DL, Breman JG. Malaria treatment and prevention in pregnancy: indications for use and adverse events associated with use of chloroquine and mefloquine. American Journal of Tropical Medicine and Hygiene 1996;55 Suppl 1:50-6.
21. Steketee RW, Wirima JJ, Slutsker L, Roberts JM, Khoromana O, Heymann DL. Malaria parasite infection during pregnancy and at delivery inmother, placenta, and newborn: efficacy of chloroquine and mefloquine in rural Malawi. American Journal of Tropical Medicine and Hygiene 1996;55 Suppl 1:24-32.
22. Steketee RW, Wirima JJ, Slutsker WL, Khoromana CO, Breman JG, Heymann DL. Objectives and methodology in a study of malaria treatment and prevention in pregnancy in rural Malawi: The Mangochi Malaria Research Project. American Journal of Tropical Medicine and Hygiene 1996;55 Suppl 1:8-16.
23. ISRCTN86353884 {published data only} ISRCTN86353884. Co-Artemether in pregnancy - a pilot study (Thailand). www.controlled-trials. com/ISRCTN86353884 (accessed February 2008).
24. Adjuik 2004 Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, White N, International Artemisinin Study Group. Artesunate combinations for treatment of malaria: meta-analysis. Lancet 2004;363(9402):9-17.
25. Brabin 2001 Brabin BJ, Rogerson SJ. The epidemiology and outcomes ofmaternal malaria. In: Duffy PE, Fried M editor(s). Malaria in pregnancy: deadly parasite, susceptible host. London and New York: Taylor & Francis, 2001:27-52.
26. Clyde 1981 Clyde DF. Clinical problems associated with the use of primaquine as a tissue schizontocidal and gametocytocidal drug. Bulletin of the World Health Organization 1981;59(3):391-5.
27. Duffy 2001 Duffy PE. Immunity to malaria during pregnancy: different host, different parasite. In: Duffy PE, Fried M editor(s). Malaria in pregnancy: deadly parasite, susceptible host. London: Taylor & Francis, 2001:71-127.
28. Gamble 2006 Gamble C, Ekwaru JP, ter Kuile FO. Insecticide-treated nets for preventing malaria in pregnancy. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD003755.pub2]
29. Garner 2006 Garner P, Gülmezoglu AM. Drugs for preventing malaria in pregnant women. Cochrane Database of Systematic Reviews 2006, Issue 4. [DOI: 10.1002/14651858.CD000169.pub2]
30. Guerin 2002 Guerin PJ, Olliaro P, Nosten F, Druilhe P, Laxminarayan R, Binka F, et al. Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development. Lancet Infectious Diseases 2002;2(9):564-73.
31. Hoffman 1992 Hoffman SL. Diagnosis, treatment, and prevention of malaria. Medical Clinics of North America 1992;76(6):1327-55.
32. Jüni 2001 Jüni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001;323(7303):42-6.
33. Lefebvre 2008 Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration, 2008. Available from www.cochrane-handbook. org.
34. Lindsay 2000 Lindsay S, Ansell J, Selman C, Cox V, Hamilton K, Walraven G. Effect of pregnancy on exposure tomalariamosquitoes. Lancet 2000;355(9219):1972.
35. Menendez 2000 Menendez C, Ordi J, Ismail MR, Ventura PJ, Aponte JJ, Kahigwa E, et al. The impact of placental malaria on gestational age and birth weight. Journal of Infectious Diseases 2000;181(5):1740-5.
36. Nosten 1993a Nosten F, ter Kuile FO, Luxemberger C, Woodrow C, Kyle DE, Chongsuphajaisiddhi T, et al. Cardiac effects of antimalarial treatment with halofantrine. Lancet 1993;341(8852):1054-6.
37. Nosten 1999 Nosten F, Vincenti M, Simpson J, Yei P, Thwai KL, de Vries A, et al. The effects of mefloquine treatment in pregnancy. Clinical Infectious Diseases 1999;28(4):808-15.
38. Nosten 2001 Nosten F, McGready R. The treatment of malaria in pregnancy. In: Duffy PE, Fried M editor(s). Malaria in pregnancy: deadly parasite, susceptible host. London: Taylor & Francis, 2001:223-41.
39. RBM 2003 Global Partnership to Roll Back Malaria, UNDP/WorldBank/WHO Special Programme for Research and Training in Tropical Diseases. Assessment of the safety of artemisinin compounds in pregnancy: report of two informal consultations convened by WHO in 2002. Geneva: World Health Organization, 2003.
40. RBM 2005a Global Partnership to Roll Back Malaria. World malaria report: 2005. Geneva: World Health Organization, 2005.
41. RBM 2005b Roll Back Malaria (RBM) Partnership. Global Strategic Plan 2005-2015. www.rollbackmalaria.org/forumV/docs/gsp_en.pdf November 2005 (accessed 1 May 2008).
42. Review Manager 5 The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
43. Steketee 2001 Steketee RE, Nahlen BL, Parise ME, Menendez C. The burden of malaria in pregnancy in malaria-endemic areas. American Journal of Tropical Medicine and Hygiene 2001;64 Suppl 1-2:28-35.
44. Stevens 2000 Stevens RD. Anaemia - the scourge of the Third World. Health Millions 2000;26(2):21-3.
45. Taylor 2004 Taylor WR, White NJ. Antimalarial drug toxicity: a review. Drug Safety 2004;27(1):25-61.
46. White 1999 White NJ, Nosten F, Looareesuwan S, Watkins WM, Mrash K, Snow RW, et al. Averting amalaria disaster. Lancet 1999;353(9168):1965-7.
47. WHO 2003a World Health Organization, Global Partnership to Roll Back Malaria. The Abuja Declaration and the plan of action: an extract from the African Summit on Roll Back Marlaria, Abuja, 25 April 2000 [WHO/CDS/RBM/2000.17]. Geneva: World Health Organization, 2003.
48. WHO 2003b World Health Organization. Lives at risk: malaria in pregnancy. www.who.int/features/2003/04b/en (accessed December 2004).
49. WHO 2003c Global Partnership to Roll Back Malaria. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparium malaria. Geneva: World Health Organization, 2003.
50. WHO 2004a World Health Organization, Regional Office for Africa. A strategic framework for malaria prevention and control during pregnancy in the African region. Brazzaville: World Health Organization, 2004.
51. WHO 2004b World Health Organization, Regional Office for Africa. Malaria control in Africa: progress report on implementation of the plan of action of the Abuja Declaration. Brazzaville: WHO Regional Office for Africa, 2004.
52. WHO 2006 World Health Organization Roll Back Malaria Department. Guidelines for the treatment of malaria [WHO/HTM/MAL/2006.1108]. Geneva: World Health Organization, 2006.
53. WHO 2007 World Health Organization Global Malaria Programme. Antimalarial drug policies: AFRO, AMRO, EMRO, EURO, SEARO, WPRO. www.who.int/malaria/treatmentpolicies.html Updated April 2007 (accessed August 2007).
54. Orton 2005 Orton L, Garner P. Drugs for treating uncomplicated malaria in pregnant women. Cochrane Database of Systematic Reviews 2005, Issue 3. [DOI: 10.1002/14651858.CD004912.pub2]